首页> 美国卫生研究院文献>BMJ Paediatrics Open >Fast I(n)dentification of Pathogens in Neonates (FINDPATH-N): protocol for a prospective pilot cohort study of next-generation sequencing for pathogen identification in neonates with suspected sepsis
【2h】

Fast I(n)dentification of Pathogens in Neonates (FINDPATH-N): protocol for a prospective pilot cohort study of next-generation sequencing for pathogen identification in neonates with suspected sepsis

机译:快速鉴定新生儿病原体(FINDPATH-N):前瞻性队列研究的协议用于下一代测序的可疑败血症新生儿病原体鉴定

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Sepsis is a major source of morbidity and mortality in neonates; however, identification of the causative pathogens is challenging. Many neonates have negative blood cultures despite clinical evidence of sepsis. Next-generation sequencing (NGS) is a high-throughput, parallel sequencing technique for DNA. Pathogen-targeted enrichment followed by NGS has the potential to be more sensitive and faster than current gold-standard blood culture. In this pilot study, we will test the feasibility and pathogen detection patterns of pathogen-targeted NGS in neonates with suspected sepsis. Additionally, the distribution and diagnostic accuracy of biomarkers cell-free DNA and protein C levels at two time points will be explored.
机译:败血症是新生儿发病和死亡的主要来源。然而,致病性病原的鉴定具有挑战性。尽管有败血症的临床证据,但许多新生儿血液培养阴性。下一代测序(NGS)是用于DNA的高通量并行测序技术。 NGS继之以病原体为目标的富集比目前的金标准血液培养具有更高的敏感性和更快的潜力。在这项初步研究中,我们将测试可疑败血症新生儿中以病原体为靶标的NGS的可行性和病原体检测模式。此外,还将探讨生物标记物在两个时间点的无细胞DNA和C蛋白水平的分布和诊断准确性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号